Page 2 - Astrazeneca Plc News Today

U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medical equipment companies accused of supporting terrorism in Iraq.

/PRNewswire/ -- The global travel vaccines market size is estimated to grow by USD 3.97 bn from 2024-2028, according to Technavio. The market is estimated to...

(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlori...

Science News: AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot seeks to cement his legacy at the British .

(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) aims to deliver $80 billion in total revenue by 2030, up from $45.8 billion in 2023. The target will be ...

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion manufacturing facility in Si...

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with higher blood eosinophil counts.

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Rare but deadly blood clots tied to J&J and AstraZeneca's vaccines were caused by an autoimmune reaction that some people are predisposed to, researchers found.

Rare and fatal blood clots linked to COVID-19 vaccines stem from an autoimmune reaction in genetically predisposed individuals.